Skip to content
Catalyst

thiamineWhat was measured

Measured, with no finding

2,290 endpoints

Show what was measuredHide what was measured
  • plasma thiamine + thiamine monophosphate, type 1 diabetic patients versus age-matched normal subjects

    decreases, p = 0.05

    The plasma content of thiamine + thiamine monophosphate in type 1 diabetic patients (35.3 +/- 3.6 pmol/mL) was significantly lower when compared with that measured in six age-matched normal subjects (53.2 +/- 2.3 pmol/mL, P < 0.05)

    PMID 10436256 · one of two readings recorded this

  • erythrocyte transketolase activation coefficient (ETK-AC)

    decreases

    The activation coefficient (ETK-AC) decreased significantly from 1.10 to 1.04 vs. 1.12 to 1.07 in both the BTMP as well as TN groups, respectively

    PMID 10507244 · one of two readings recorded this

  • erythrocyte transketolase activation coefficient (ETK-AC)

    decreases

    The activation coefficient (ETK-AC) decreased significantly from 1.10 to 1.04 vs. 1.12 to 1.07 in both the BTMP as well as TN groups, respectively

    PMID 10507244 · one of two readings recorded this

  • TDP AUC0-24h in whole blood, BTMP versus TN

    increases

    The AUC0-24h of TDP in whole blood after BTMP ingestion exceeded those after TN ingestion by 420%

    PMID 10507244 · one of two readings recorded this

  • TDP concentration in whole blood, fold increase from baseline to Cmax

    increases

    The TDP concentration in whole blood increased by 2.6 and 1.4 times from baseline levels to Cmax in the BTMP and TN groups, respectively

    PMID 10507244 · one of two readings recorded this

  • TDP concentration in whole blood, fold increase from baseline to Cmax

    increases

    The TDP concentration in whole blood increased by 2.6 and 1.4 times from baseline levels to Cmax in the BTMP and TN groups, respectively

    PMID 10507244 · one of two readings recorded this

  • urinary excretion of administered dose

    Only 1.0 vs. 0.6% of the administered dose were excreted in urine in the BTMP group and TN group, respectively

    PMID 10507244 · one of two readings recorded this

  • urinary excretion of administered dose

    Only 1.0 vs. 0.6% of the administered dose were excreted in urine in the BTMP group and TN group, respectively

    PMID 10507244 · one of two readings recorded this

  • fibroblast pyruvate dehydrogenase activity at normal thiamine pyrophosphate concentration

    decreases

    pyruvate dehydrogenase activity was studied again with thiamine pyrophosphate concentration adjusted to the normal human tissue level and found to be deficient

    PMID 10872106 · one of two readings recorded this

  • fibroblast pyruvate dehydrogenase activity with routine assay

    no effect

    Fibroblast pyruvate dehydrogenase assayed with routine method was normal

    PMID 10872106 · one of two readings recorded this

  • neurological status after thiamine treatment

    increases

    because of neurological improvement after treatment with thiamine, pyruvate dehydrogenase activity was studied again

    PMID 10872106 · one of two readings recorded this

  • alpha-ETK (transketolase activation coefficient)

    decreases, p = 0.04

    Likewise, alpha-ETK decreased from initially 1.10+/-0.07 to 1.04+/-0.04 (P = 0.04) and from 1.12+/-0.05 to 1.08+/-0.06 (P = 0.09)

    PMID 10952481 · one of two readings recorded this

  • alpha-ETK (transketolase activation coefficient)

    no effect, p = 0.09

    Likewise, alpha-ETK decreased from initially 1.10+/-0.07 to 1.04+/-0.04 (P = 0.04) and from 1.12+/-0.05 to 1.08+/-0.06 (P = 0.09)

    PMID 10952481 · one of two readings recorded this

  • erythrocyte thiamine diphosphate concentration and erythrocyte transketolase activity after single oral benfotiamine 100 mg versus thiamine nitrate 100 mg in ESRD patients

    ratio of maximum erythrocyte TDP to basal 2.66+/-0.6 (benfotiamine) versus 1.44+/-0.2 (thiamine nitrate)

    Not recorded as a finding: the comparison was against another active treatment

    The ratio between the maximum erythrocyte TDP concentration and basal concentration was 2.66+/-0.6 in the benfotiamine group and 1.44+/-0.2 in the group receiving thiamine nitrate (P < 0.001).

    PMID 10952481 · one of two readings recorded this

  • erythrocyte transketolase activity

    increases, p = 0.02

    The transketolase activity increased from 3.54+/-0.7 microkat/l initially to 3.84+/-0.6 microkat/l after benfotiamine intake (P = 0.02) and from 3.71+/-0.8 microkat/l to 4.02+/-0.7 microkat/l after thiamine nitrate intake (P = 0.08)

    PMID 10952481 · one of two readings recorded this

  • erythrocyte transketolase activity

    no effect, p = 0.08

    The transketolase activity increased from 3.54+/-0.7 microkat/l initially to 3.84+/-0.6 microkat/l after benfotiamine intake (P = 0.02) and from 3.71+/-0.8 microkat/l to 4.02+/-0.7 microkat/l after thiamine nitrate intake (P = 0.08)

    PMID 10952481 · one of two readings recorded this

  • peak plasma TDP concentration in ESRD patients versus healthy subjects

    increases

    After benfotiamine administration, the peak plasma concentration of TDP exceeded that in healthy subjects by 51%

    PMID 10952481 · one of two readings recorded this

  • phosphorylation ratio in whole blood

    decreases, p = 0.02

    After 24 h, the phosphorylation ratio in whole blood decreased from 12.9+/-6.9 initially to 5.6+/-3.2 after benfotiamine administration (P = 0.02) and from 13.5+/-7.3 to 9.0+/-4.8 (P = 0.03) after administration of thiamine nitrate

    PMID 10952481 · one of two readings recorded this

  • phosphorylation ratio in whole blood

    decreases, p = 0.03

    After 24 h, the phosphorylation ratio in whole blood decreased from 12.9+/-6.9 initially to 5.6+/-3.2 after benfotiamine administration (P = 0.02) and from 13.5+/-7.3 to 9.0+/-4.8 (P = 0.03) after administration of thiamine nitrate

    PMID 10952481 · one of two readings recorded this

  • ratio of erythrocyte TDP concentration to basal concentration

    increases

    After 24 h, it was 2.11+/-0.4 and 1.23+/-0.2, respectively

    PMID 10952481 · one of two readings recorded this

  • ratio of erythrocyte TDP concentration to basal concentration

    increases

    After 24 h, it was 2.11+/-0.4 and 1.23+/-0.2, respectively

    PMID 10952481 · one of two readings recorded this

  • ratio of maximum to basal erythrocyte TDP concentration

    increases, p = 0.001

    The ratio between the maximum erythrocyte TDP concentration and basal concentration was 2.66+/-0.6 in the benfotiamine group and 1.44+/-0.2 in the group receiving thiamine nitrate (P < 0.001)

    PMID 10952481 · one of two readings recorded this

  • ratio of maximum to basal erythrocyte TDP concentration

    increases, p = 0.001

    The ratio between the maximum erythrocyte TDP concentration and basal concentration was 2.66+/-0.6 in the benfotiamine group and 1.44+/-0.2 in the group receiving thiamine nitrate (P < 0.001)

    PMID 10952481 · one of two readings recorded this

  • TDP blood AUC, benfotiamine versus thiamine nitrate

    increases

    the patients with ESRD had a 4.3 times higher area under the concentration time curve after benfotiamine administration than after thiamine nitrate

    PMID 10952481 · one of two readings recorded this

  • TDP concentration in erythrocytes

    increases

    In the ESRD patients, after 24 h, the mean TDP concentration in erythrocytes increased from 158.7+/-30.9 ng/ml initially to 325.8+/-50.9 ng/ml after administration of benfotiamine and from 166.2+/-51.9 ng/ml to 200.5+/-50.0 ng/ml after thiamine nitrate administration

    PMID 10952481 · one of two readings recorded this

  • TDP concentration in erythrocytes

    increases

    In the ESRD patients, after 24 h, the mean TDP concentration in erythrocytes increased from 158.7+/-30.9 ng/ml initially to 325.8+/-50.9 ng/ml after administration of benfotiamine and from 166.2+/-51.9 ng/ml to 200.5+/-50.0 ng/ml after thiamine nitrate administration

    PMID 10952481 · one of two readings recorded this

  • mean plasma thiamine level

    n = 70

    Seventy patients participated and had a mean plasma thiamine level of 27.3 microg/dL (95% CI = 20.2 to 34.4)

    PMID 11015250 · one of two readings recorded this

  • mean plasma thiamine level

    than patients receiving dietary support (n = 44, 31.5 microg/dL, 95% CI = 24.7 to 38.3, 7% thiamine-deficient)

    PMID 11015250 · one of two readings recorded this

  • mean plasma thiamine level

    decreases

    Patients not receiving dietary supplements or tube feedings (n = 26) had lower mean thiamine levels (20.3 microg/dL, 95% CI = 12.7 to 27.9) and were thiamine-deficient more often (27%)

    PMID 11015250 · one of two readings recorded this

  • prevalence of thiamine deficiency (<10 microg/dL)

    Fourteen percent (n = 10, 95% CI = 8% to 24%) were thiamine-deficient (<10 microg/dL)

    PMID 11015250 · one of two readings recorded this

  • prevalence of thiamine deficiency (<10 microg/dL)

    than patients receiving dietary support (n = 44, 31.5 microg/dL, 95% CI = 24.7 to 38.3, 7% thiamine-deficient)

    PMID 11015250 · one of two readings recorded this

  • prevalence of thiamine deficiency (<10 microg/dL)

    increases

    Patients not receiving dietary supplements or tube feedings (n = 26) had lower mean thiamine levels (20.3 microg/dL, 95% CI = 12.7 to 27.9) and were thiamine-deficient more often (27%)

    PMID 11015250 · one of two readings recorded this

  • high thiamine pyrophosphate effect (TPPE >15%), indicating thiamine deficiency

    increases, p = 0.057, n = 28

    High (>15%) thiamine pyrophosphate effect (TPPE), indicating thiamine deficiency, was found in five out of 14 CLL patients (35.7%) and in none of the controls (p=0.057)

    PMID 11524517 · one of two readings recorded this

  • increment of more than 20% in total leucocyte count over the preceding three months

    increases

    which was found in all five thiamine deficient patients compared with only one of the nine non-thiamine deficient CLL patients

    PMID 11524517 · one of two readings recorded this

  • mean TPPE in thiamine deficient CLL patients

    Mean (SD) TPPE in the thiamine deficient patients group was 21.6 (3.4)%

    PMID 11524517 · one of two readings recorded this

  • thiamine status by thiamine pyrophosphate effect (TPPE) in untreated B-CLL patients versus controls

    increases, p = 0.057, n = 28

    Not recorded as a finding: the compound is what was measured, not what was given

    High (>15%) thiamine pyrophosphate effect (TPPE), indicating thiamine deficiency, was found in five out of 14 CLL patients (35.7%) and in none of the controls (p=0.057).

    PMID 11524517 · one of two readings recorded this

  • association of ETKA with maternal symptoms or thiamine supplement use

    no effect

    No significant associations between ETKA and putative maternal symptoms or use of thiamine supplements were found

    PMID 11722964 · one of two readings recorded this

  • severe thiamine deficiency by erythrocyte transketolase activity (ETKA > 1.25%)

    thiamine deficiency reflected by an erythrocyte transketolase activity (ETKA) > or = 1.20% was found in 57.7% (15/26) of mothers, 26.9% (7/26) of whom had severe deficiency (ETKA > 1.25%)

    PMID 11722964 · one of two readings recorded this

  • thiamine deficiency by erythrocyte transketolase activity (ETKA >= 1.20%)

    thiamine deficiency reflected by an erythrocyte transketolase activity (ETKA) > or = 1.20% was found in 57.7% (15/26) of mothers, 26.9% (7/26) of whom had severe deficiency (ETKA > 1.25%)

    PMID 11722964 · one of two readings recorded this

  • thiamine status by erythrocyte transketolase activity (ETKA) at 3 months postpartum in Karen refugee women

    no effect, no significant association between ETKA and use of thiamine supplements

    Not recorded as a finding: the compound is what was measured, not what was given

    No significant associations between ETKA and putative maternal symptoms or use of thiamine supplements were found.

    PMID 11722964 · one of two readings recorded this

  • maximum blood concentration (Cmax) of thiamine and AUC of thiamine and thiamine pyrophosphate after 150 mg i.v. over 1 h versus 24 h

    increases, Cmax 2300 ng/mL after rapid infusion versus 177 ng/mL after slower infusion

    Not recorded as a finding: the comparison was against another active treatment

    The maximum blood concentrations (Cmax) of thiamine were significantly higher after the more rapid infusion (RI; 2300 ng/mL) than after the slower infusion (SI; 177 ng/mL).

    PMID 12605618 · one of two readings recorded this

  • thiamine Cmax, AUC, thiamine pyrophosphate AUC and urinary excretion of thiamine after 150 mg i.v. over 1 h versus 24 h

    no effect, AUC of thiamine identical after both infusion protocols

    Not recorded as a finding: the comparison was against another active treatment

    The AUC of thiamine was identical after both infusion protocols.

    PMID 12605618 · one of two readings recorded this

  • thiamine Cmax in blood

    decreases, n = 12

    The maximum blood concentrations (Cmax) of thiamine were significantly higher after the more rapid infusion (RI; 2300 ng/mL) than after the slower infusion (SI; 177 ng/mL)

    PMID 12605618 · one of two readings recorded this

  • TPP AUC, slower versus rapid infusion

    increases, p = 0.08, n = 12

    There was a slightly (10%) increased AUC of TPP (P < 0.08) after SI

    PMID 12605618 · one of two readings recorded this

  • urinary excretion of thiamine, percent of applied dose

    decreases, n = 12

    Urinary excretion of thiamine was significantly decreased from 83.6% of the applied dose after RI to 57.6% after the SI

    PMID 12605618 · one of two readings recorded this

  • erythrocyte thiamine diphosphate (TDP)

    decreases

    TDP=127.4+/-62.5 nmol/l (P<10(-5))

    PMID 12742126 · one of two readings recorded this

  • erythrocyte thiamine diphosphate (TDP)

    Mean control values obtained were: T=89.6+/-22.7 nmol/l, TMP=4.4+/-6.6 nmol/l and TDP=222.23+/-56.3 nmol/l

    PMID 12742126 · one of two readings recorded this

  • erythrocyte thiamine monophosphate (TMP)

    Mean control values obtained were: T=89.6+/-22.7 nmol/l, TMP=4.4+/-6.6 nmol/l and TDP=222.23+/-56.3 nmol/l

    PMID 12742126 · one of two readings recorded this

  • erythrocyte thiamine (T)

    decreases, p = 0.001

    T and TDP mean values of alcoholics were significantly lower than those of control cases: T=69.4+/-35.9 nmol/l (P<0.001)

    PMID 12742126 · one of two readings recorded this

  • erythrocyte thiamine (T)

    Mean control values obtained were: T=89.6+/-22.7 nmol/l, TMP=4.4+/-6.6 nmol/l and TDP=222.23+/-56.3 nmol/l

    PMID 12742126 · one of two readings recorded this

  • 24-h copper balance during CRRT

    decreases

    The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI)

    PMID 15277163 · one of two readings recorded this

  • 24-h selenium balance during CRRT

    decreases

    The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI)

    PMID 15277163 · one of two readings recorded this

  • 24-h thiamine balance during CRRT

    decreases

    The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI)

    PMID 15277163 · one of two readings recorded this

  • 24-h zinc balance during CRRT

    increases

    The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI)

    PMID 15277163 · one of two readings recorded this

  • thiamine 24-h balance (fluids administered minus effluent losses) during continuous venovenous hemodiafiltration, compared with recommended parenteral intake

    -4.12 mg, or 1.5 times the RI

    Not recorded as a finding: the compound is what was measured, not what was given

    The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI).

    PMID 15277163 · one of two readings recorded this

  • correlation of vitamin B1 level with cerebellar size

    increases, p = 0.028

    vitamin B1 level correlated with cerebellar size in alcoholics even if the vitamin B1 concentration was within normal values (r = 0.344, p = 0.028)

    PMID 15778906 · one of two readings recorded this

  • dentate nuclei MRI signal intensity

    no effect, p = 0.15

    dentate nuclei intensity was not significantly decreased in patients with chronic alcohol consumption (mean +/- SD signal intensity 65.36 +/- 13.0) if compared with control subjects (mean +/- SD signal intensity 68.95 +/- 9.4) (p = 0.15)

    PMID 15778906 · one of two readings recorded this

  • anaemia and diabetes mellitus response to thiamine

    unclear

    The anaemia and diabetes mellitus responded to oral thiamine hydrochloride 25 mg/d, but during puberty thiamine supplements became ineffective

    PMID 16373304 · one of two readings recorded this

  • anaemia and diabetes mellitus response to thiamine

    no effect

    The anaemia and diabetes mellitus responded to oral thiamine hydrochloride 25 mg/d, but during puberty thiamine supplements became ineffective

    PMID 16373304 · one of two readings recorded this

  • T158R missense mutation in control alleles

    no effect, n = 100

    We have identified a novel missense mutation (T158R) that was excluded in 100 control alleles

    PMID 16373304 · one of two readings recorded this

  • oxidative stress, inflammatory and nutritional markers (albumin, hsCRP, IL-6, AOPP, pentosidine, 8-OHdG)

    no effect, n = 40

    In both groups, over 8 weeks of follow-up, no significant differences could be observed in oxidative stress, inflammatory, or nutritional markers

    PMID 16567267 · one of two readings recorded this

  • serum albumin, plasma hsCRP, IL-6, advanced oxidation protein products, pentosidine and 8-hydroxy-2'-deoxyguanosine in hemodialysis patients over 8 weeks

    no effect, no significant differences in oxidative stress, inflammatory or nutritional markers

    Not recorded as a finding: the intervention held more than the compound

    In both groups, over 8 weeks of follow-up, no significant differences could be observed in oxidative stress, inflammatory, or nutritional markers.

    PMID 16567267 · one of two readings recorded this

  • serum albumin, plasma hsCRP, IL-6, advanced oxidation protein products, pentosidine and 8-hydroxy-2'-deoxyguanosine in hemodialysis patients

    no effect, no evidence that high doses of thiamine and pyridoxine affect oxidative stress, n = 40

    Not recorded as a finding: the intervention held more than the compound

    There was no evidence showing that high doses of thiamine and pyridoxine affects oxidative stress in hemodialysis patients.

    PMID 16567267 · one of two readings recorded this

  • mean preoperative thiamine level

    Male patients presented with greater mean preoperative thiamine levels (3.2 microg /dL) than female patients (2.4 microg/dL)

    PMID 16925281 · one of two readings recorded this

  • mean preoperative thiamine level

    Male patients presented with greater mean preoperative thiamine levels (3.2 microg /dL) than female patients (2.4 microg/dL)

    PMID 16925281 · one of two readings recorded this

  • prevalence of low preoperative thiamine levels

    Forty-seven patients (15.5%) presented with low preoperative thiamine levels.

    PMID 16925281 · one of two readings recorded this

  • lower limb neuropathy after spinal anesthesia

    n = 1

    We present the case of a 65-year-old man with latent thiamine deficiency who manifested lower limb neuropathy after receiving spinal anesthesia

    PMID 17175435 · one of two readings recorded this

  • Neuropathy Symptom Score and Total Symptom Score after 6 weeks of benfotiamine 300 or 600 mg/day versus placebo

    no effect, TSS showed no significant differences after 6 weeks

    Not recorded as a finding: the paper never mentions the compound

    The TSS (Total Symptom Score) showed no significant differences after 6 weeks of treatment.

    PMID 18473286 · one of two readings recorded this

  • Neuropathy Symptom Score (NSS), intention-to-treat population

    unclear, p = 0.055, n = 133

    In the ITT (intention to treat) population, the improvement of NSS was slightly above significance (p=0.055)

    PMID 18473286 · one of two readings recorded this

  • Neuropathy Symptom Score (NSS), per-protocol population

    decreases, p = 0.033, n = 124

    After 6 weeks of treatment, the primary outcome parameter NSS (Neuropathy Symptom Score) differed significantly between the treatment groups (p=0.033) in the PP (per protocol) population

    PMID 18473286 · one of two readings recorded this

  • Neuropathy Symptom Score (NSS, primary) and Total Symptom Score (TSS) after 6 weeks of benfotiamine 300 or 600 mg/day versus placebo in diabetic polyneuropathy

    no effect, TSS showed no significant differences after 6 weeks

    Not recorded as a finding: the paper never mentions the compound

    The TSS (Total Symptom Score) showed no significant differences after 6 weeks of treatment.

    PMID 18473286 · one of two readings recorded this

  • blood thiamine levels (nmol/L) and proportion below 150 nmol/L under a cereal-rich versus a vegetable-rich hypocaloric diet

    increases, blood thiamine levels increased only with diet C at 2 and 6 weeks, n = 57

    Not recorded as a finding: this platform holds no node for the endpoint

    Thiamine intake and blood thiamine levels only increased with diet C (both at 2 and 6 weeks).

    PMID 18608543 · one of two readings recorded this

  • blood thiamine levels (proportion below 150 nmol/L) in overweight/obese women on a cereal-based versus a vegetable-based hypocaloric diet

    increases, blood thiamine levels increased only with the cereal diet at 2 and 6 weeks

    Not recorded as a finding: this platform holds no node for the endpoint

    Thiamine intake and blood thiamine levels only increased with diet C (both at 2 and 6 weeks).

    PMID 18608543 · one of two readings recorded this

  • proportion of women with blood thiamine below 150 nmol/L

    decreases

    at 6 weeks of intervention only 3.7% of the women in diet C, as compared with 30.8% of the women in diet V, showed blood thiamine levels <150 nmol/L

    PMID 18608543 · one of two readings recorded this

  • proportion of women with blood thiamine below 150 nmol/L

    unclear

    at 6 weeks of intervention only 3.7% of the women in diet C, as compared with 30.8% of the women in diet V, showed blood thiamine levels <150 nmol/L

    PMID 18608543 · one of two readings recorded this

  • anion gap

    group 1 (21.4%) with a normal anion gap (5.5 +/- 5.2 mmol/l) and group 2 (78.6%) with a wide anion gap (21.2 +/- 5.2 mmol/l)

    PMID 18613556 · one of two readings recorded this

  • anion gap

    group 1 (21.4%) with a normal anion gap (5.5 +/- 5.2 mmol/l) and group 2 (78.6%) with a wide anion gap (21.2 +/- 5.2 mmol/l)

    PMID 18613556 · one of two readings recorded this

  • high lactate level

    33.3% had a high lactate level (2.2 mmol/l); none had thiamine deficiency (TPPE < 20%)

    PMID 18613556 · one of two readings recorded this

  • high lactate level

    High lactate (3.5 +/- 1.4 mmol/l) was found in 54.5% of group 2 and thiamine deficiency was observed in 18.2% of this group

    PMID 18613556 · one of two readings recorded this

  • normal lactate level

    Sixty-six point seven percent of patients in group 1 had a normal lactate level (1.5 +/- 0.8 mmol/l)

    PMID 18613556 · one of two readings recorded this

  • thiamine deficiency by TPPE

    no effect

    33.3% had a high lactate level (2.2 mmol/l); none had thiamine deficiency (TPPE < 20%)

    PMID 18613556 · one of two readings recorded this

  • thiamine deficiency by TPPE

    High lactate (3.5 +/- 1.4 mmol/l) was found in 54.5% of group 2 and thiamine deficiency was observed in 18.2% of this group

    PMID 18613556 · one of two readings recorded this

  • Days of glucose infusion before Wernicke's encephalopathy

    decreases

    The five subjects with albumin plasma levels lower than 35 g/L at the onset of WE received glucose infusion for fewer days

    PMID 18929463 · one of two readings recorded this

  • Persistent mental dysfunction with Korsakoff's syndrome despite prolonged thiamine treatment

    In one case mental function did not normalize and the patient developed Korsakoff's syndrome despite prolonged thiamine treatment

    PMID 18929463 · one of two readings recorded this

  • Resolution of clinical signs the day after thiamine infusion

    decreases

    In six cases the clinical signs disappeared the day after thiamine infusion

    PMID 18929463 · one of two readings recorded this

  • Time from start of glucose infusion to onset of Wernicke's encephalopathy

    WE occurred, on average, 13 d after the start of glucose infusion

    PMID 18929463 · one of two readings recorded this

  • change in urinary albumin excretion (UAE) from baseline

    no effect, n = 20

    There was no significant decrease in UAE in patients receiving placebo after 3 months of therapy (n = 20)

    PMID 19057893 · one of two readings recorded this

  • change in urinary albumin excretion (UAE) from baseline

    decreases, p = 0.001, n = 20

    UAE was decreased in patients receiving thiamine therapy for 3 months with respect to baseline (median -17.7 mg/24 h; p < 0.001, n = 20)

    PMID 19057893 · one of two readings recorded this

  • urinary albumin excretion (UAE) at 3 months, thiamine versus placebo

    decreases, p = 0.01

    UAE was significantly lower in patients who had received thiamine therapy compared with those who had received placebo (30.1 vs 35.5 mg/24 h, p < 0.01)

    PMID 19057893 · one of two readings recorded this

  • urinary albumin excretion (UAE), mg/24 h, assay not stated, thiamine 3 x 100 mg/day versus placebo for 3 months

    decreases, UAE 30.1 vs 35.5 mg/24 h, thiamine vs placebo, n = 40

    Not recorded as a finding: the paper never states the instrument the node requires

    UAE was significantly lower in patients who had received thiamine therapy compared with those who had received placebo (30.1 vs 35.5 mg/24 h, p < 0.01) but not at baseline.

    PMID 19057893 · one of two readings recorded this

  • urinary albumin excretion (UAE), mg/24 h, thiamine 3 x 100 mg/day versus placebo for 3 months

    decreases, UAE 30.1 vs 35.5 mg/24 h, thiamine versus placebo

    Not recorded as a finding: the paper never states the instrument the node requires

    UAE was significantly lower in patients who had received thiamine therapy compared with those who had received placebo (30.1 vs 35.5 mg/24 h, p < 0.01) but not at baseline.

    PMID 19057893 · one of two readings recorded this

  • folate above upper limit of reference range among patients with low thiamine diphosphate

    n = 39

    28 (72%) of the 39 had folate levels higher than the upper limit of the reference range

    PMID 19083422 · one of two readings recorded this

  • folate above upper limit of reference range among patients with normal thiamine

    p = 0.01, n = 41

    In 41 patients with normal thiamine levels, only 14 (34%) had folate levels higher than the upper limit of the reference range (chi(2) test, P < .01)

    PMID 19083422 · one of two readings recorded this

  • repeated thiamine diphosphate level after oral antibiotic therapy

    increases, n = 9

    Nine of these patients then received oral antibiotic therapy; repeated thiamine levels were found to be normal in all 9 patients

    PMID 19083422 · one of two readings recorded this

  • repeated thiamine diphosphate level after oral thiamine supplements

    no effect, n = 15

    Fifteen patients received oral thiamine supplements, but repeated thiamine levels remained low in all 15

    PMID 19083422 · one of two readings recorded this

  • thiamine diphosphate below lower limit of reference range

    n = 80

    In these 80 patients, 39 (49%) had thiamine diphosphate levels less than the lower limit of the reference range

    PMID 19083422 · one of two readings recorded this

  • heart rate after exercise

    decreases, n = 27

    after exercise, heart rate was lower after taking TPP than after placebo

    PMID 19094430 · one of two readings recorded this

  • heart rate at rest

    no effect, n = 27

    At rest, heart rate after taking placebo or TPP was similar

    PMID 19094430 · one of two readings recorded this

  • maximum oxygen consumption (Vo(2max)) during exercise

    increases, n = 27

    During exercise, Vo(2max) in athletes on TPP was higher than on placebo

    PMID 19094430 · one of two readings recorded this

  • serum lactate after exercise

    decreases, n = 27

    after exercise, the levels were lower in the athletes after taking TPP than after placebo

    PMID 19094430 · one of two readings recorded this

  • serum lactate at rest

    no effect, n = 27

    At rest, serum lactate levels after placebo or TPP were similar

    PMID 19094430 · one of two readings recorded this

  • serum lactate, maximum oxygen consumption (VO2max) and heart rate in male athletes after TPP 1 mg/kg versus placebo, crossover

    increases, VO2max higher on TPP than on placebo

    Not recorded as a finding: the paper never mentions the compound

    During exercise, Vo(2max) in athletes on TPP was higher than on placebo.

    PMID 19094430 · one of two readings recorded this

  • serum lactate, Vo(2max) and heart rate at rest and after exercise, thiamine pyrophosphate 1 mg/kg versus placebo

    increases, Vo(2max) higher on TPP than on placebo, n = 27

    Not recorded as a finding: the paper never mentions the compound

    During exercise, Vo(2max) in athletes on TPP was higher than on placebo.

    PMID 19094430 · one of two readings recorded this

  • age at independent walking

    unclear, p = 0.001

    The study and control groups differed significantly in the expressive communication (p<0.001) and auditory comprehension language subscales (p<0.001), the Mental Developmental Index score (p<0.001), and age at independent walking (p=0.001)

    PMID 19191836 · one of two readings recorded this

  • auditory comprehension language subscale

    unclear, p = 0.001

    The study and control groups differed significantly in the expressive communication (p<0.001) and auditory comprehension language subscales (p<0.001), the Mental Developmental Index score (p<0.001), and age at independent walking (p=0.001)

    PMID 19191836 · one of two readings recorded this

  • correlation of receptive language score with age at independent walking

    unclear, p = 0.005

    A significant correlation was found between the receptive language score and age at independent walking, i.e. poorer language associated with later walking (r=-0.601, p=0.005)

    PMID 19191836 · one of two readings recorded this

  • expressive communication language subscale

    unclear, p = 0.001

    The study and control groups differed significantly in the expressive communication (p<0.001) and auditory comprehension language subscales (p<0.001), the Mental Developmental Index score (p<0.001), and age at independent walking (p=0.001)

    PMID 19191836 · one of two readings recorded this

  • Mental Developmental Index score

    unclear, p = 0.001

    The study and control groups differed significantly in the expressive communication (p<0.001) and auditory comprehension language subscales (p<0.001), the Mental Developmental Index score (p<0.001), and age at independent walking (p=0.001)

    PMID 19191836 · one of two readings recorded this

  • preoperative thiamine blood concentration

    no effect

    Preoperative thiamine blood concentrations were within the normal range in both groups

    PMID 19342609 · one of two readings recorded this

  • thiamine blood concentration below normal range

    decreases, n = 7

    Among the 7 patients receiving peripheral parenteral nutrition without thiamine, the thiamine concentration in 3 patients was below the normal range on the fifth postoperative day

    PMID 19342609 · one of two readings recorded this

  • thiamine blood concentration over postoperative days 1 to 5 in children on peripheral parenteral nutrition with or without thiamine

    Not recorded as a finding: this platform holds no node for the endpoint

    In the group receiving peripheral parenteral nutrition without thiamine, the thiamine concentration gradually decreased with time after the operation, whereas the concentration remained within the normal range in the group receiving peripheral parenteral nutrition with thiamine.

    PMID 19342609 · one of two readings recorded this

  • thiamine blood concentration over time after operation

    no effect

    whereas the concentration remained within the normal range in the group receiving peripheral parenteral nutrition with thiamine

    PMID 19342609 · one of two readings recorded this

  • thiamine blood concentration over time after operation

    decreases

    In the group receiving peripheral parenteral nutrition without thiamine, the thiamine concentration gradually decreased with time after the operation

    PMID 19342609 · one of two readings recorded this

  • Anemia

    decreases

    We report a 4-year-old girl with TRMA whose anemia improved following administration of thiamine

    PMID 19347672 · one of two readings recorded this

  • absence of missense variants in healthy controls

    n = 50

    the absence of the missense variants in healthy normals was confirmed in 50 unrelated individuals (i.e. 100 chromosomes)

    PMID 19643445 · one of two readings recorded this

  • hearing in compound heterozygote Patient 2

    Notably, in one case (Patient 2), a compound heterozygote, the hearing is normal even at 15 years of age

    PMID 19643445 · one of two readings recorded this

  • novel SLC19A2 mutations identified

    By determining the sequence of SLC19A2 in all probands we identified nine novel mutations amongst these seven families

    PMID 19643445 · one of two readings recorded this

  • sensory-neural hearing deficit in compound heterozygote Patient 5

    Another compound heterozygote (Patient 5) has only minimal sensory-neural hearing deficit at 30 years of age

    PMID 19643445 · one of two readings recorded this

  • Reversion of clinical features including cardiologic abnormalities to normalcy

    Low levels of erythrocyte transketolase activity suggested thiamine deficiency that was confirmed by reversion of several clinical features including cardiologic abnormalities to normalcy on thiamine supplementation

    PMID 19934228 · one of two readings recorded this

  • Abnormal prenatal brain development with severe non-progressive encephalopathy

    n = 12

    Abnormal prenatal brain development resulted in severe non-progressive encephalopathy with callosal agenesis, gyration anomalies, microcephaly with intrauterine growth retardation, or dysmorphia in both males and females (12 cases)

    PMID 20002125 · one of two readings recorded this

  • Acute energy failure in infant life producing basal ganglia lesions, paroxysmal dystonia, neuropathic ataxia or epilepsy

    n = 11

    Acute energy failure in infant life produced basal ganglia lesions with paroxysmal dystonia, neuropathic ataxia due to axonal transport dysfunction, or epilepsy only in males (11 cases)

    PMID 20002125 · one of two readings recorded this

  • Mutations involving PDHA1

    n = 17

    Seventeen mutations involved PDHA1 (a hotspot was identified in exons 6, 7, and 8 in seven males with Leigh syndrome or recurrent ataxia)

    PMID 20002125 · one of two readings recorded this

  • Paroxysmal dysfunction

    decreases

    The ketogenic diet improved only paroxysmal dysfunction, providing an additional argument in favour of paroxysmal energy failure

    PMID 20002125 · one of two readings recorded this

  • PDHX mutations correlated with non-progressive encephalopathy and long-term survival

    n = 5

    Mutations in the PDHX gene (five cases) were correlated with non-progressive encephalopathy and long-term survival in four cases

    PMID 20002125 · one of two readings recorded this

  • plasma thiamine, change from pre-CABG to 24 hours

    decreases, p = 0.003

    pre- to 24 hour thiamine levels were also statistically significantly lower (mean of differences= 8.5 nmol/Liters; [95% CI 3.6-13.3], p = 0.003)

    PMID 20005469 · one of two readings recorded this

  • plasma thiamine, change from pre-CABG to 6 hours

    no effect, p = 0.052

    however pre- to 6 hour levels were not significantly lower (mean of differences = 5.8 nmol/Liters [−.06 – 11.7], p = 0.052)

    PMID 20005469 · one of two readings recorded this

  • plasma thiamine, change from pre-CABG to immediately post-CABG

    decreases, p = 0.0004

    there was a statistically significant decrease in thiamine levels between the baseline (pre-CABG) and post-CABG serum thiamine levels (mean of differences = 10.14 nmol/Liters; [95% CI 5.6 – 14.7], p = 0.0004)

    PMID 20005469 · one of two readings recorded this

  • plasma thiamine level (HPLC thiochrome) before and after coronary artery bypass graft surgery; surgery is the exposure, thiamine is measured

    decreases, mean of differences 10.14 nmol/L, 95% CI 5.6-14.7, p = 0.0004

    Not recorded as a finding: the compound is what was measured, not what was given

    For the primary endpoint, there was a statistically significant decrease in thiamine levels between the baseline (pre-CABG) and post-CABG serum thiamine levels (mean of differences = 10.14 nmol/Liters; [95% CI 5.6 – 14.7], p = 0.0004).

    PMID 20005469 · one of two readings recorded this

  • HDL cholesterol

    no effect, p = 0.25

    HDL cholesterol (mmol/l) | 1.2 ± 0.3 | 1.1 ± 0.3 | 1.2 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.3 | 0.25

    PMID 20413516 · one of two readings recorded this

  • LDL cholesterol

    no effect, p = 0.55

    LDL cholesterol (mmol/l) | 1.9 ± 0.7 | 1.9 ± 0.8 | 2.1 ± 0.8 | 1.8 ± 0.9 | 1.8 ± 0.9 | 1.9 ± 0.9 | 0.55

    PMID 20413516 · one of two readings recorded this

  • Triglycerides

    no effect, p = 0.06

    Triglycerides (mmol/l) | 1.8 (1.4–2.6) | 1.9 (1.4–2.8) | 1.7 (1.2–2.6) | 2.1 (1.4–3.4) | 2.2 (1.4–2.9) | 2.0 (1.2–2.9) | 0.06

    PMID 20413516 · one of two readings recorded this

  • 24-h UACR

    no effect, p = 0.37

    24-h UACR (mg/mmol) | 10.3 (3.7–23.4) | 6.1 (3.0–17.7) | 4.9 (2.5–18.4) | 7.6 (4.3–13.3) | 7.4 (2.8–11.0) | 7.1 (4.0–12.5) | 0.37

    PMID 20413516 · one of two readings recorded this

  • 24-h UAE change from baseline to 12 weeks

    no effect

    Change in UAE between baseline and 12 weeks was −18 mg/24 h in the benfotiamine group and −1 mg/24 h in the placebo group

    PMID 20413516 · one of two readings recorded this

  • 24-h urinary albumin excretion, immunonephelometry (primary outcome)

    no effect, Benfotiamine treatment had no significant effect on primary or secondary outcome parameters.

    Not recorded as a finding: The only prose sentence is a generic statement over all primary and secondary outcomes and does not name UAE; node urinary-albumin-excretion-rate requires a timed collection expressed as micrograms per minute, the paper reports mg/24 h.

    Benfotiamine treatment had no significant effect on primary or secondary outcome parameters.

    PMID 20413516 · one of two readings recorded this

  • 24-h urinary albumin excretion (UAE, immunonephelometry) and urinary KIM-1 (ELISA) after 12 weeks of benfotiamine vs placebo in type 2 diabetes with nephropathy

    no effect

    Not recorded as a finding: the paper never mentions the compound

    Benfotiamine treatment had no significant effect on primary or secondary outcome parameters.

    PMID 20413516 · one of two readings recorded this

  • 24-h urinary albumin excretion (UAE)

    no effect, p = 0.36

    UAE (mg/24 h) | 90 (38–267) | 75 (49–280) | 72 (38–199) | 97 (48–177) | 99 (43–200) | 96 (45–200) | 0.36

    PMID 20413516 · one of two readings recorded this

  • 24-h urinary KIM-1

    no effect, p = 0.12

    U-KIM-1 (μg/24 h) | 1.67 (0.95–2.47) | 1.51 (0.86–2.59) | 1.68 (1.06–2.40) | 1.56 (1.06–1.83) | 1.56 (1.06–1.83) | 1.39 (1.02–2.01) | 0.12

    PMID 20413516 · one of two readings recorded this

  • Creatinine clearance

    no effect, p = 0.57

    Creatinine clearance (ml/min) | 135 ± 51 | 129 ± 53 | 133 ± 45 | 130 ± 58 | 139 ± 58 | 131 ± 64 | 0.57

    PMID 20413516 · one of two readings recorded this

  • Cystatin C

    no effect, p = 0.53

    Cystatin C (mg/l) | 1.01 ± 0.21 | 1.06 ± 0.22 | 1.09 ± 0.23 | 1.03 ± 0.23 | 1.10 ± 0.26 | 1.11 ± 0.23 | 0.53

    PMID 20413516 · one of two readings recorded this

  • Diastolic blood pressure

    no effect, p = 0.68

    DBP (mmHg) | 76 ± 8 | 77 ± 10 | 76 ± 9 | 76 ± 10 | 76 ± 9 | 76 ± 10 | 0.68

    PMID 20413516 · one of two readings recorded this

  • Erythrocyte transketolase activity

    increases, p = 0.001

    TK activity (mU/mgHb) | 0.41 ± 0.10 | 0.51 ± 0.12 | 0.53 ± 0.15 | 0.38 ± 0.11 | 0.39 ± 0.08 | 0.41 ± 0.10 | <0.001

    PMID 20413516 · one of two readings recorded this

  • HbA1c

    no effect, p = 0.33

    A1C (%) | 7.3 ± 0.9 | 7.1 ± 0.9 | 7.3 ± 1.0 | 7.4 ± 0.9 | 7.2 ± 0.9 | 7.2 ± 0.9 | 0.33

    PMID 20413516 · one of two readings recorded this

  • Plasma creatinine

    increases, p = 0.04

    Plasma creatinine (μmol/l) | 84 ± 19 | 89 ± 19 | 88 ± 20 | 87 ± 23 | 89 ± 25 | 87 ± 21 | 0.04

    PMID 20413516 · one of two readings recorded this

  • Spot-urine UACR

    no effect, p = 0.58

    Spot-urine UACR (mg/mmol) | 9.3 (2.4–16.8) | 5.8 (3.7–17.9) | 7.1 (3.6–17.8) | 6.2 (3.4–10.5) | 8.2 (3.9–14.2) | 8.1 (4.6–15.9) | 0.58

    PMID 20413516 · one of two readings recorded this

  • Systolic blood pressure

    no effect, p = 0.6

    SBP (mmHg) | 140 ± 16 | 139 ± 14 | 143 ± 17 | 137 ± 20 | 140 ± 20 | 140 ± 17 | 0.60

    PMID 20413516 · one of two readings recorded this

  • Urinary alpha1-microglobulin (24 h)

    no effect, p = 0.33

    U-α1m (mg/24 h) | 9.4 (4.3–24.4) | 11.9 (4.4–20.2) | 11.2 (4.1–18.8) | 8.2 (4.3–20.3) | 9.0 (5.7–21.1) | 10.2 (2.5–19.7) | 0.33

    PMID 20413516 · one of two readings recorded this

  • Urinary alpha1-microglobulin/creatinine

    no effect, p = 0.47

    U-α1m/creatinine (mg/mmol) | 0.6 (0.3–1.4) | 0.7 (0.3–1.3) | 0.6 (0.3–1.2) | 0.6 (0.3–1.3) | 0.6 (0.3–1.4) | 0.7 (0.2–1.1) | 0.47

    PMID 20413516 · one of two readings recorded this

  • Urinary KIM-1/creatinine

    no effect, p = 0.37

    U-KIM-1/creatinine (ng/mmol) | 103 (63–158) | 95 (66–170) | 96 (77–148) | 99 (79–141) | 89 (58–130) | 81 (66–150) | 0.37

    PMID 20413516 · one of two readings recorded this

  • Urinary NGAL (24 h)

    no effect, p = 0.17

    U-Ngal (mg/24 h) | 131 (67–227) | 118 (77–229) | 115 (73–284) | 122 (53–224) | 112 (52–218) | 99 (52–222) | 0.17

    PMID 20413516 · one of two readings recorded this

  • Urinary NGAL/creatinine

    no effect, p = 0.18

    U-Ngal/creatinine (mg/mmol) | 6.7 (4.3–13.9) | 6.2 (3.4–15.9) | 5.1 (3.2–12.9) | 7.7 (4.2–18.9) | 6.4 (3.2–15.1) | 8.5 (3.3–13.1) | 0.18

    PMID 20413516 · one of two readings recorded this

  • whole-blood thiamine and erythrocyte transketolase activity (thiamine status), HPLC

    increases, parameters of thiamine status improved significantly

    Not recorded as a finding: No outcome node for whole-blood thiamine or transketolase activity.

    In patients receiving benfotiamine, parameters of thiamine status improved significantly.

    PMID 20413516 · one of two readings recorded this

  • Whole blood thiamine

    increases, p = 0.001

    Whole blood thiamine (nmol/l) | 126 ± 23 | 290 ± 31 | 300 ± 0 | 122 ± 23 | 124 ± 25 | 138 ± 30 | <0.001

    PMID 20413516 · one of two readings recorded this

  • Absolute thiamine deficiency prevalence

    n = 30

    None of the 30 controls (0/30, 0%) exhibited absolute TD

    PMID 20646908 · one of two readings recorded this

  • Absolute thiamine deficiency prevalence

    n = 30

    In the study group, 3 (10%) of 30 had absolute TD upon presentation

    PMID 20646908 · one of two readings recorded this

  • Absolute thiamine deficiency prevalence

    n = 26

    Of the vasopressor-dependent population, 7.7% (2/26) displayed TD on presentation

    PMID 20646908 · one of two readings recorded this

  • Additional absolute thiamine deficiency developing

    n = 30

    an additional 3 patients (6/30, 20%) developed TD within 72 hours

    PMID 20646908 · one of two readings recorded this

  • Association of plasma thiamine with lactic acidosis after multivariable regression

    decreases, p = 0.02

    The relationship between thiamine and lactic acidosis held after multivariable regression analysis controlling for age, sex, and comorbid disease (P < .02)

    PMID 20646908 · one of two readings recorded this

  • Correlation between plasma thiamine and lactic acidosis

    no effect

    For the group overall, there was no correlation between thiamine and lactic acidosis

    PMID 20646908 · one of two readings recorded this

  • Correlation between plasma thiamine and lactic acidosis

    decreases, p = 0.02

    thiamine was statistically significantly negatively correlated with lactic acidosis (r = -.50; P = .02)

    PMID 20646908 · one of two readings recorded this

  • fasting glucose, A1C, lipids, hs-CRP, IL-6, TNF-alpha, leptin and adiponectin before and after 1 month of thiamine 150 mg/day versus placebo

    decreases, glucose 6.7 ± 1.0 vs 6.0 ± 1.0 mmol/l before and after thiamine, p = 0.024

    Not recorded as a finding: the result compares a group with itself, not with a control

    There were significant decreases in glucose (6.7 ± 1.0 mmol/l vs. 6.0 ± 1.0 mmol/l, p = 0.024) before and after the intervention, respectively, and leptin concentrations (32.9 ± 13.3 ng/ml vs. 26.9 ± 12.8 ng/ml, p = 0.027) before and after the intervention, respectively, with thiamine administration.

    PMID 20652275 · one of two readings recorded this

  • fasting glucose and leptin before and after 1 month of thiamine 150 mg versus placebo in drug-naive type 2 diabetes

    decreases, glucose 6.7 to 6.0 mmol/l; leptin 32.9 to 26.9 ng/ml, before vs after on thiamine, p = 0.024, n = 12

    Not recorded as a finding: the result compares a group with itself, not with a control

    There were significant decreases in glucose (6.7 ± 1.0 mmol/l vs. 6.0 ± 1.0 mmol/l, p = 0.024) before and after the intervention, respectively, and leptin concentrations (32.9 ± 13.3 ng/ml vs. 26.9 ± 12.8 ng/ml, p = 0.027) before and after the intervention, respectively, with thiamine administration.

    PMID 20652275 · one of two readings recorded this

  • fasting glucose

    decreases, p = 0.024

    There were significant decreases in glucose (6.7 ± 1.0 mmol/l vs. 6.0 ± 1.0 mmol/l, p = 0.024) before and after the intervention

    PMID 20652275 · one of two readings recorded this

  • leptin

    decreases, p = 0.027

    leptin concentrations (32.9 ± 13.3 ng/ml vs. 26.9 ± 12.8 ng/ml, p = 0.027) before and after the intervention, respectively, with thiamine administration

    PMID 20652275 · one of two readings recorded this

  • memory performance in relation to whole blood thiamine level

    Thiamine levels were selectively related to memory performance in the alcoholics

    PMID 20962766 · one of two readings recorded this

  • proportion of alcoholics at risk for WE (one criterion)

    Of the alcoholics examined, 27% met no criteria, 57% were at risk for WE, and 16% had signs of WE

    PMID 20962766 · one of two readings recorded this

  • proportion of alcoholics meeting no Caine criteria for WE

    Of the alcoholics examined, 27% met no criteria, 57% were at risk for WE, and 16% had signs of WE

    PMID 20962766 · one of two readings recorded this

  • proportion of alcoholics with signs of WE (two or more criteria)

    Of the alcoholics examined, 27% met no criteria, 57% were at risk for WE, and 16% had signs of WE

    PMID 20962766 · one of two readings recorded this

  • Association of low blood thiamine with C-reactive protein >20 mg/dL

    increases, p = 0.02, n = 202

    independently associated with C-reactive protein concentrations >20 mg/dL (odds ratio: 2.17; 95% CI: 1.13, 4.17; P = 0.02)

    PMID 21068344 · one of two readings recorded this

  • Association of low blood thiamine with malnutrition

    no effect, n = 202

    but not with malnutrition

    PMID 21068344 · one of two readings recorded this

  • Association of low blood thiamine with mortality, length of stay and mechanical ventilation time

    no effect, n = 202

    No significant association was shown between low blood thiamine concentrations upon admission and outcome variables

    PMID 21068344 · one of two readings recorded this

  • Prevalence of low blood thiamine upon admission

    n = 202

    Low blood thiamine concentrations upon admission were detected in 57 patients (28.2%)

    PMID 21068344 · one of two readings recorded this

  • whole-blood thiamine concentration by HPLC on PICU admission as risk-factor outcome and predictor of mortality, length of stay and ventilation time

    no effect

    Not recorded as a finding: the compound is what was measured, not what was given

    No significant association was shown between low blood thiamine concentrations upon admission and outcome variables.

    PMID 21068344 · one of two readings recorded this

  • left ventricular ejection fraction (LVEF) treatment effect, absolute

    increases, n = 9

    This corresponds to a treatment effect for LVEF of 3.9% in absolute terms

    PMID 22057652 · one of two readings recorded this

  • left ventricular ejection fraction (LVEF)

    no effect, p = 0.911, n = 9

    Baseline LVEF was similar for both treatment groups (29.5% in the thiamine group and 29.5% in the placebo group, P = 0.911)

    PMID 22057652 · one of two readings recorded this

  • left ventricular ejection fraction (LVEF)

    increases, p = 0.024, n = 9

    After 28 days of thiamine treatment, the LVEF increased to 32.8% which was significantly (P = 0.024) different from the LVEF in the placebo group (28.8%)

    PMID 22057652 · one of two readings recorded this

  • Blood thiamine

    decreases

    Blood thiamine, mammillary bodies and fornix volume, and fornix fiber bundle fractional anisotropy were significantly decreased as compared to controls

    PMID 22172599 · one of two readings recorded this

  • Correlation of blood thiamine with mammillary bodies' volume

    increases

    Blood thiamine showed significant positive correlation with mammillary bodies' volume only

    PMID 22172599 · one of two readings recorded this

  • Reversibility of blood thiamine and mammillary bodies' volume

    increases, n = 7

    In 7 acute liver failure patients, follow-up study was done after clinical recovery at 5 weeks

    PMID 22172599 · one of two readings recorded this

  • AGE-DNA (DNA glycation) in DNA isolated from leukocytes, in diabetic nephropathy patients given vitamins B1 + B6 versus B6 alone

    decreases, significant decrease in AGE-DNA values with combined B1 and B6

    Not recorded as a finding: this platform holds no node for the endpoint

    The combined administration of B(1) and B(6) caused a significant decrease in AGE-DNA values (p<0.05).

    PMID 22231921 · one of two readings recorded this

  • AGE-DNA (glycation of leukocyte nuclear DNA) after vitamins B1 + B6 versus B6 alone in diabetic nephropathy

    decreases, significant decrease in AGE-DNA with B1 + B6, n = 6

    Not recorded as a finding: this platform holds no node for the endpoint

    The combined administration of B(1) and B(6) caused a significant decrease in AGE-DNA values (p<0.05).

    PMID 22231921 · one of two readings recorded this

  • AGE-DNA in leukocytes

    increases, p = 0.05

    AGE-DNA levels were found significantly higher in diabetic patients (p<0.05) than the healthy controls

    PMID 22231921 · one of two readings recorded this

  • AGE-DNA in leukocytes

    decreases, p = 0.05, n = 6

    The combined administration of B(1) and B(6) caused a significant decrease in AGE-DNA values (p<0.05)

    PMID 22231921 · one of two readings recorded this

  • AGE-DNA in leukocytes

    no effect, n = 11

    Importantly the administration of vitamin B(6) alone did not have such an effect

    PMID 22231921 · one of two readings recorded this

  • correlation of AGE-DNA with PLP

    decreases, p = 0.05, n = 30

    AGE-DNA and PLP levels were negatively correlated in control patients (r= - 0.361, p<0.05)

    PMID 22231921 · one of two readings recorded this

  • effect of dose on AUC0-10 hr, plasma

    increases, p = 0.001

    The overall effect of dose was significant (Plasma: ANOVA p < 0.001; Whole Blood: ANOVA p < 0.001)

    PMID 22305197 · one of two readings recorded this

  • effect of dose on AUC0-10 hr, whole blood

    increases, p = 0.001

    The overall effect of dose was significant (Plasma: ANOVA p < 0.001; Whole Blood: ANOVA p < 0.001)

    PMID 22305197 · one of two readings recorded this

  • pairwise comparison of mean AUC0-10 hr between doses

    increases, p = 0.05

    the mean AUC0-10 hr for each dose was also significantly different from the others (Student-Newman-Keuls procedure, p < 0.05)

    PMID 22305197 · one of two readings recorded this

  • plasma and whole-blood total thiamine AUC0-10 hr, Cmax, Tmax and half-life after oral thiamine hydrochloride 100, 500 and 1500 mg, HPLC thiochrome

    overall effect of dose significant for plasma and whole blood

    Not recorded as a finding: this platform holds no node for the endpoint

    The overall effect of dose was significant (Plasma: ANOVA p < 0.001; Whole Blood: ANOVA p < 0.001).

    PMID 22305197 · one of two readings recorded this

  • slope of AUC0-10 hr vs dose

    unclear, p = 0.4

    whole blood | 2.14 | 0.40

    PMID 22305197 · one of two readings recorded this

  • slope of AUC0-10 hr vs dose

    unclear, p = 0.01

    whole blood | 1.02 | < 0.01 | 0.14 | < 0.01

    PMID 22305197 · one of two readings recorded this

  • slope of AUC0-10 hr vs dose

    unclear, p = 0.06

    whole blood | 1.42 | 0.06 | 0.29 | 0.03

    PMID 22305197 · one of two readings recorded this

  • slope of Cmax vs dose

    unclear, p = 0.01

    whole blood | 1.02 | < 0.01 | 0.14 | < 0.01

    PMID 22305197 · one of two readings recorded this

  • slope of Cmax vs dose

    unclear, p = 0.03

    whole blood | 1.42 | 0.06 | 0.29 | 0.03

    PMID 22305197 · one of two readings recorded this

  • incident open-angle glaucoma cases over follow-up

    n = 91

    During a mean follow-up of 9.7 years (range 5.3–13.9 years), 91 (2.6%) developed OAG

    PMID 22461101 · one of two readings recorded this

  • incident open-angle glaucoma defined by glaucomatous visual field loss at follow-up, Cox hazard ratio by tertile of dietary vitamin B1 intake from food frequency questionnaire

    decreases

    Not recorded as a finding: this platform holds no node for the endpoint

    High intakes of retinol equivalents and vitamin B1 were associated with a decreased risk of OAG, whereas a high intake of magnesium was associated with an increased risk.

    PMID 22461101 · one of two readings recorded this

  • incident open-angle glaucoma

    p = 0.063

    2nd | 1.62 (0.97–2.71; 0.063) | 0.99 (0.52–1.86; 0.966)

    PMID 22461101 · one of two readings recorded this

  • incident open-angle glaucoma

    p = 0.966

    2nd | 1.62 (0.97–2.71; 0.063) | 0.99 (0.52–1.86; 0.966)

    PMID 22461101 · one of two readings recorded this

  • incident open-angle glaucoma

    p = 0.795

    3rd | 1.08 (0.59–2.00; 0.795) | 0.97 (0.47–2.00; 0.930)

    PMID 22461101 · one of two readings recorded this

  • incident open-angle glaucoma

    p = 0.93

    3rd | 1.08 (0.59–2.00; 0.795) | 0.97 (0.47–2.00; 0.930)

    PMID 22461101 · one of two readings recorded this

  • incident open-angle glaucoma

    p = 0.076

    2nd | 0.54 (0.27–1.07; 0.076) | 0.53 (0.21–1.35; 0.185)

    PMID 22461101 · one of two readings recorded this

The whole record — 2,290 rows